Hypermarcas (OTCMKTS:HYPMY - Get Free Report) declared a dividend on Monday, June 23rd, investing.com reports. Stockholders of record on Tuesday, July 1st will be paid a dividend of 0.0345 per share on Friday, January 8th. This represents a dividend yield of 2.81%. The ex-dividend date of this dividend is Monday, June 30th.
Hypermarcas Trading Down 1.8%
Shares of Hypermarcas stock opened at $4.86 on Monday. Hypermarcas has a 52-week low of $2.64 and a 52-week high of $5.92. The company has a quick ratio of 0.80, a current ratio of 1.26 and a debt-to-equity ratio of 0.63. The company's 50-day simple moving average is $4.20 and its 200-day simple moving average is $3.56. The firm has a market cap of $3.08 billion, a price-to-earnings ratio of 20.23 and a beta of 0.79.
Hypermarcas (OTCMKTS:HYPMY - Get Free Report) last issued its earnings results on Wednesday, April 23rd. The company reported ($0.04) earnings per share for the quarter. Hypermarcas had a return on equity of 6.95% and a net margin of 12.51%. The company had revenue of $184.34 million for the quarter.
Hypermarcas Company Profile
(
Get Free Report)
Hypera SA operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, Max Sulid, milgamma, Mioflex A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, Pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Hypermarcas, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hypermarcas wasn't on the list.
While Hypermarcas currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
